Clinical Trial Update: MRI Iron Oxide Imaging for Lymph Node Staging in Esophageal Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial of MRI iron oxide imaging for lymph node staging in esophageal cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Esophageal Cancer | Phase 1 | Status: WITHDRAWN